NCT07521605 2026-04-13
Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer
Guangdong Provincial People's Hospital
Phase 2 Not yet recruiting
Clinical Trials
6 trialsNCT07337811 2026-01-13
Selective Total Mesorectal Excision Based on Intra-Operative Frozen Section From Local Excision in Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
Sun Yat-sen University
Phase NA Recruiting
NCT07291401 2025-12-18
Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC
Zhongnan Hospital
Phase 2 Not yet recruiting
NCT07214142 2025-10-09
TNT-Immunity
The First Affiliated Hospital of University of Science and Technology of China
Phase 2 Not yet recruiting
NCT06824688 2025-09-19
Single-port Versus Multi-port Robotic Surgery for Rectal Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase NA Recruiting
NCT01426074 2018-08-21
DCE-MRI PET Bevacizumab Study in Rectal Cancer
Abramson Cancer Center at Penn Medicine
Phase 2 Withdrawn